Concepedia

Tiera Liby

TL

Statistics

Publications

9

Citations

510

H-Index

9

Active since

2011

Affiliations

Oregon Health & Science University(Current)

Harvard University

The University of Texas MD Anderson Cancer Center

Center for Systems Biology

Icahn School of Medicine at Mount Sinai

Tiera Liby is an author at Oregon Health & Science University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2011–2023

9

Publications

9

A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines

Mario Niepel, Marc Hafner, Caitlin E. Mills et al. · Cell Systems · 2019 · 143 citations · Full text

, , +13

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

Spencer S. Watson, Mark Dane, Koei Chin et al. · Cell Systems · 2018 · 100 citations · Full text

, , +17

Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease

Rebecca Smith, Moqing Liu, Tiera Liby et al. · Scientific Reports · 2020 · 76 citations · Full text

, , +17

Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects

Sean M. Gross, Farnaz Mohammadi, Crystal Sanchez-Aguila et al. · Nature Communications · 2023 · 48 citations · Full text

, , +17

Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells

Tiera Liby, Perry Spyropoulos, Haley Buff Lindner et al. · International Journal of Cancer · 2011 · 39 citations · Full text

, , +17

1–5 of 9